CA2460150A1 - Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis - Google Patents
Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis Download PDFInfo
- Publication number
- CA2460150A1 CA2460150A1 CA002460150A CA2460150A CA2460150A1 CA 2460150 A1 CA2460150 A1 CA 2460150A1 CA 002460150 A CA002460150 A CA 002460150A CA 2460150 A CA2460150 A CA 2460150A CA 2460150 A1 CA2460150 A1 CA 2460150A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- compounds
- ring
- group
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/961,538 US6784199B2 (en) | 2000-09-21 | 2001-09-21 | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals |
| US09/961,542 | 2001-09-21 | ||
| US09/961,542 US6768008B2 (en) | 2000-04-24 | 2001-09-21 | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US09/961,538 | 2001-09-21 | ||
| US10/228,670 US20030054974A1 (en) | 2001-08-24 | 2002-08-26 | Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| US10/228,670 | 2002-08-26 | ||
| PCT/US2002/030017 WO2003024943A2 (en) | 2000-04-24 | 2002-09-20 | Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2460150A1 true CA2460150A1 (en) | 2003-03-27 |
Family
ID=49447234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002460150A Abandoned CA2460150A1 (en) | 2001-09-21 | 2002-09-20 | Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1430039A2 (ja) |
| JP (1) | JP2005527475A (ja) |
| KR (1) | KR20040062545A (ja) |
| CA (1) | CA2460150A1 (ja) |
| NZ (1) | NZ532261A (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100829468B1 (ko) * | 2007-01-17 | 2008-05-16 | 한국화학연구원 | 신규한 1,2,4-티아다이아졸리딘-3,5-다이온 화합물 및 이의제조방법 |
-
2002
- 2002-09-20 JP JP2003528791A patent/JP2005527475A/ja not_active Withdrawn
- 2002-09-20 CA CA002460150A patent/CA2460150A1/en not_active Abandoned
- 2002-09-20 NZ NZ532261A patent/NZ532261A/en unknown
- 2002-09-20 KR KR10-2004-7004172A patent/KR20040062545A/ko not_active Application Discontinuation
- 2002-09-20 EP EP02763686A patent/EP1430039A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1430039A2 (en) | 2004-06-23 |
| JP2005527475A (ja) | 2005-09-15 |
| KR20040062545A (ko) | 2004-07-07 |
| NZ532261A (en) | 2006-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6768008B2 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
| CA2457054C (en) | Activator of peroxisome proliferator-activated receptor .delta. | |
| EP1480642B1 (en) | Peroxisome proliferator activated receptor modulators | |
| JP2005529077A (ja) | ペルオキシソーム増殖因子活性化受容体調節物質 | |
| Reddy et al. | Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives | |
| JP2000514041A (ja) | 抗糖尿病、低脂血、抗高血圧特性を有するチアゾリジンジオン化合物、それらの調製法、及びその薬学的組成物 | |
| Lohray et al. | Novel euglycemic and hypolipidemic agents. 4. Pyridyl-and quinolinyl-containing thiazolidinediones | |
| JPH10194970A (ja) | 置換チアゾリジンジオン誘導体を含む抗高脂血剤 | |
| KR20050119201A (ko) | ５원 헤테로방향족 고리 화합물 및 이의 의약적 용도 | |
| JP2006514069A (ja) | Ｐｐａｒ調節因子としての融合複素環式誘導体 | |
| US6784199B2 (en) | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals | |
| ES2364150T3 (es) | Derivados del ácido butanoico, procesos para su preparación, composiciones farmacéuticas que los comprenden y sus aplicaciones terapéuticas. | |
| US6680387B2 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
| US6958355B2 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
| CA2402123A1 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
| WO2006117743A1 (en) | Substituted aromatic compounds as antidiabetic agents | |
| US20060047000A1 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
| CA2460150A1 (en) | Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis | |
| AU2002327683A1 (en) | Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis | |
| EP1207156B1 (en) | Substituted benzylthiazolidine-2,4-dione derivatives | |
| ZA200401945B (en) | Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis. | |
| Shinkai et al. | 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |